Book a demo

Chemical intelligence powered by cypris.ai

Methyl phenanthrene

1-methylphenanthrene · also: 1-Methyl phenanthrene · 1-methyl-phenanthrene

FormulaC15H12
Mol. weight192.261
PubChem CID13257
InChIKeyDOWJXOHBNXRUOD-UHFFFAOYSA-N
SMILESCC1=C2C=CC3=CC=CC=C3C2=CC=C1
1,033Patents
39Research papers
66Patents - last 3 years
1Papers - last 3 years

Who owns the IP

The organizations most actively patenting around this compound, ranked by referenced patent volume.

#AssigneePatents
1BASF SE68
2Daiichi Sankyo Co Ltd60
3Mitsui Chemicals Inc31
4Fujifilm Holdings Corp25
5Nippon Steel Corp25
6Nissan Chemical Corp25
7Mitsubishi Gas Chemical Co Inc16
8Exxon Mobil Corp14
9Tosoh Corp14
10China National Petroleum Corp13

Explore the full landscape

This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.

Visit Cypris

Where innovation is concentrated

Patent classifications ranked by volume reveal the technical domains with the most active filing.

#CodeAreaPatents
1C07DHeterocyclic compounds316
2A61PTherapeutic activity (drug indications)226
3A61KMedicinal preparations179
4C07CAcyclic and carbocyclic compounds172
5C08FPolymers from C=C unsaturated bonds129
6Y02PClimate change mitigation: production90
7C09KMaterials for misc. applications89
8C08GPolymers from non-vinyl bonds (e.g. polyamides, polyesters)88
9G01NInvestigating / analysing materials84
10C07HSugars and derivatives83

AI mapped opportunity space

This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.

See Cypris in action

Representative patents

The filings that best characterise the patent activity around this compound, most-referenced first.

TitleYearAssigneeCited by
Nucleoside and oligonucleotide analogues2008Daiichi Sankyo Co Ltd204
COMPOUNDS FOR ELECTRONIC DEVICES2010Merck KGaA181
Nucleoside and oligonucleotide analogues2008Daiichi Sankyo Co Ltd165
Organic light-emitting device201674
Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use1997Daiichi Sankyo Co Ltd185

How research activity has moved

Papers published per year for this compound, over the last decade of indexed records.

YearPapers
20164
20171
20241

Who's driving the science

The most-published authors working with this compound, alongside their primary affiliations.

#AuthorAffiliationPapers
1Daphnee S. PushparajahUniversity of Surrey4
2Costas IoannidesUniversity of Surrey4
3Nick PlantUniversity of Surrey3
4Yvonne C.M. StaalMaastricht University3
5Frederik‐Jan van SchootenMaastricht University3
6Meera UmachandranUniversity of Surrey3
7Kathryn E. PlantUniversity of Surrey3
8Joost H.M. van DelftMaastricht University3
9Marcel H. M. van HerwijnenMaastricht University3
10Jianan ZhongSun Yat-sen University2

Research leaders

This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.

See Cypris in action

The literature that defines it

The most-cited papers anchoring the scientific record for this compound.

Frequently asked questions

Common questions about this compound's patent and research landscape, answered from the underlying data.

What is the molecular composition of methyl phenanthrene?

Methyl phenanthrene has the molecular formula C15H12 with a molecular weight of 192.261. The canonical name is 1-methylphenanthrene, and it is also known by the synonyms methyl phenanthrene and 1-methyl-phenanthrene.

Which organizations hold the most patents involving methyl phenanthrene?

BASF SE holds the largest patent portfolio with 68 patents, followed by Daiichi Sankyo Co Ltd with 60 patents and Mitsui Chemicals Inc with 31 patents. Other significant patent holders include Fujifilm Holdings Corp, Nippon Steel Corp, and Nissan Chemical Corp, each with 25 patents.

What are the main research topics associated with methyl phenanthrene in scientific literature?

Research on methyl phenanthrene spans several topics including thermochemical biomass conversion processes, toxic organic pollutants impact, atmospheric chemistry and aerosols, and advanced chemical physics studies. Key papers address solvent-extractable polycyclic aromatic hydrocarbons in biochar, toxicity of alkyl-phenanthrenes to early life stages, PAH mixture effects on gene expression and DNA adduct formation, PAH presence in urban atmospheres, and electronic absorption spectroscopy of phenanthrene cations.

What is the patent trend for methyl phenanthrene over the past decade?

Patent activity involving methyl phenanthrene has fluctuated over the years tracked, with 35 patents in 2016, peaking at 48 patents in 2022, and declining to 39 patents in 2024. In the last 3 years, 66 patents have been filed. The overall patent database contains 1,033 patents related to methyl phenanthrene.

Which chemical classifications are most frequently associated with methyl phenanthrene patents?

The most common CPC subclass is C07D with 316 patents, followed by A61P (pharmaceutical preparations) with 226 patents and A61K (medicaments) with 179 patents. Other frequently used classifications include C07C (acyclic or cyclic hydrocarbons), C08F (macromolecular compounds), Y02P (climate change mitigation technologies), and C09K (miscellaneous materials), collectively accounting for significant portions of the patent portfolio.

Turn any compound into a complete chemical intelligence landscape

Go beyond static compound data. Cypris resolves identities, patents, papers, and commercial signals into one AI-powered view - so your team can move from a single chemical question to a complete R&D, IP, and market landscape.

Schedule a free trial